HK1091216A1 - Growth factor complexes and modulation of cell migration and growth - Google Patents
Growth factor complexes and modulation of cell migration and growthInfo
- Publication number
- HK1091216A1 HK1091216A1 HK06111795.8A HK06111795A HK1091216A1 HK 1091216 A1 HK1091216 A1 HK 1091216A1 HK 06111795 A HK06111795 A HK 06111795A HK 1091216 A1 HK1091216 A1 HK 1091216A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein complexes
- cell migration
- growth
- growth factor
- vitronectin
- Prior art date
Links
- 239000003102 growth factor Substances 0.000 title abstract 3
- 230000012292 cell migration Effects 0.000 title abstract 2
- 230000010261 cell growth Effects 0.000 title 1
- 102000007474 Multiprotein Complexes Human genes 0.000 abstract 3
- 108010085220 Multiprotein Complexes Proteins 0.000 abstract 3
- 102100037362 Fibronectin Human genes 0.000 abstract 2
- 108010067306 Fibronectins Proteins 0.000 abstract 2
- 102100035140 Vitronectin Human genes 0.000 abstract 2
- 108010031318 Vitronectin Proteins 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 102000009465 Growth Factor Receptors Human genes 0.000 abstract 1
- 108010009202 Growth Factor Receptors Proteins 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 abstract 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 abstract 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000010393 epithelial cell migration Effects 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003900481A AU2003900481A0 (en) | 2003-02-05 | 2003-02-05 | Synthetic modulators of cell migration and growth |
| PCT/AU2004/000117 WO2004069871A1 (en) | 2003-02-05 | 2004-02-05 | Growth factor complexes and modulation of cell migration and growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1091216A1 true HK1091216A1 (en) | 2007-01-12 |
Family
ID=30005181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06111795.8A HK1091216A1 (en) | 2003-02-05 | 2006-10-25 | Growth factor complexes and modulation of cell migration and growth |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7659367B2 (xx) |
| EP (3) | EP1594895B1 (xx) |
| JP (2) | JP4717799B2 (xx) |
| KR (2) | KR101175687B1 (xx) |
| CN (1) | CN1774448B (xx) |
| AT (1) | ATE521636T1 (xx) |
| AU (1) | AU2003900481A0 (xx) |
| CA (1) | CA2515335C (xx) |
| DK (1) | DK1594895T3 (xx) |
| ES (1) | ES2372388T3 (xx) |
| HK (1) | HK1091216A1 (xx) |
| NZ (1) | NZ541738A (xx) |
| WO (1) | WO2004069871A1 (xx) |
| ZA (1) | ZA200506991B (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8871709B2 (en) * | 2003-02-05 | 2014-10-28 | Queensland University of Technolgy | Synthetic chimeric proteins comprising epidermal growth factor and vitronectin |
| AU2003903896A0 (en) * | 2003-07-28 | 2003-08-07 | Queensland University Of Technology | Skin regeneration system |
| US20070004037A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for culturing keratinocytes |
| US20070128685A1 (en) * | 2005-07-01 | 2007-06-07 | Rodolfo Faudoa | Methods and compositions for cell culture |
| US20070004036A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for keratinocyte culture |
| US20070003541A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for therapeutics |
| AU2006274438A1 (en) * | 2005-07-29 | 2007-02-01 | Australian Stem Cell Centre Limited | Compositions and methods for growth of pluripotent cells |
| EP2131750B1 (en) * | 2007-03-06 | 2016-05-04 | Covidien LP | Wound closure material |
| US20100076489A1 (en) * | 2007-03-06 | 2010-03-25 | Joshua Stopek | Wound closure material |
| BRPI1009325A2 (pt) | 2009-03-19 | 2016-03-08 | Univ Queensland | alvos para sinalização do fator de crescimento e método de terapia |
| EP2507261B1 (en) * | 2009-11-30 | 2016-12-21 | Factor Therapeutics Limited | Fibronectin: growth factor chimeras |
| US9133266B2 (en) * | 2011-05-06 | 2015-09-15 | Wisconsin Alumni Research Foundation | Vitronectin-derived cell culture substrate and uses thereof |
| SI2782598T1 (sl) * | 2011-11-23 | 2020-12-31 | In3Bio Ltd. | Rekombinantni proteini in njihove terapevtske uporabe |
| AU2014240878A1 (en) * | 2013-03-29 | 2015-09-24 | Merrimack Pharmaceuticals, Inc. | Cartilage-binding fusion proteins |
| KR101558498B1 (ko) | 2013-04-26 | 2015-10-12 | 건국대학교 산학협력단 | 노년황반변성의 진단, 치료 및 예방용 조성물 및 노년황반변성에 대한 진단 방법 |
| JP6169710B2 (ja) * | 2013-09-10 | 2017-07-26 | 富士フイルム株式会社 | 多能性幹細胞の培養方法、培養用キット及び多能性幹細胞培養用培地 |
| WO2016105332A1 (en) * | 2014-12-22 | 2016-06-30 | Avon Products, Inc. | Peptides and their use in the treatment of skin |
| US20170281507A1 (en) * | 2014-12-23 | 2017-10-05 | Avon Products, Inc. | Peptides and Their Use in the Treatment of Skin |
| US20170304178A1 (en) * | 2014-12-23 | 2017-10-26 | Avon Products, Inc. | Peptides and Their Use in the Treatment of Skin |
| CN107108757B (zh) * | 2015-03-11 | 2021-10-19 | 新源生物科技股份有限公司 | 包含vegf及pdgf的配体结合域的融合蛋白 |
| WO2019010533A1 (en) * | 2017-07-12 | 2019-01-17 | Factor Therapeutics Limited | TREATMENT OF OCULAR DISORDERS |
| WO2023233340A1 (en) * | 2022-06-02 | 2023-12-07 | Avant Meats Company Limited | Genetically engineered yeast cells, recombinant proteins produced thereof and applications thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US592904A (en) | 1897-11-02 | Drill | ||
| US4849338A (en) | 1982-07-16 | 1989-07-18 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
| US4843000A (en) | 1979-12-26 | 1989-06-27 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| CA1341598C (en) | 1988-07-15 | 2009-09-29 | Central Sydney Area Health Service | Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| US6090790A (en) | 1989-12-14 | 2000-07-18 | Eriksson; Elof | Gene delivery by microneedle injection |
| JP2866134B2 (ja) * | 1990-02-05 | 1999-03-08 | 寳酒造株式会社 | 機能性ポリペプチド |
| EP0542874A4 (en) | 1990-07-25 | 1994-05-11 | Syngene Inc | Circular extension for generating multiple nucleic acid complements |
| US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| JP2829405B2 (ja) * | 1991-10-14 | 1998-11-25 | 寳酒造株式会社 | 機能性ポリペプチド |
| US5958764A (en) | 1992-04-30 | 1999-09-28 | Baylor College Of Medicine | Specific expression vectors and methods of use |
| WO1994018232A1 (en) | 1993-02-12 | 1994-08-18 | Repligen Corporation | Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
| US5422252A (en) | 1993-06-04 | 1995-06-06 | Becton, Dickinson And Company | Simultaneous amplification of multiple targets |
| US5962427A (en) | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
| AUPM672594A0 (en) | 1994-07-08 | 1994-08-04 | Royal Children's Hospital Research Foundation | A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| WO1997019193A2 (en) | 1995-11-21 | 1997-05-29 | Yale University | Unimolecular segment amplification and detection |
| US5752019A (en) | 1995-12-22 | 1998-05-12 | International Business Machines Corporation | System and method for confirmationally-flexible molecular identification |
| US5835382A (en) | 1996-04-26 | 1998-11-10 | The Scripps Research Institute | Small molecule mimetics of erythropoietin |
| US6077987A (en) | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
| AU3192299A (en) | 1998-03-18 | 1999-10-11 | Wake Forest University | Improved implantable biomaterials, compositions and methods for their preparation and uses thereof |
| US6436897B2 (en) | 1998-06-01 | 2002-08-20 | Celtrix Pharmaceuticals, Inc. | Pharmaceutical formulations for IGF/IGFBP |
| JP2001190280A (ja) * | 1999-02-19 | 2001-07-17 | Terumo Corp | コラーゲン結合性生理活性ポリペプチド |
| AU3897200A (en) | 1999-03-18 | 2000-10-04 | Hope Heart Institute, The | Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor |
| JP2002060400A (ja) * | 2000-08-17 | 2002-02-26 | Terumo Corp | コラーゲン結合活性および血管新生調節活性を有するハイブリッドポリペプチド |
| AUPR030900A0 (en) * | 2000-09-22 | 2000-10-12 | Queensland University Of Technology | Growth factor complex |
-
2003
- 2003-02-05 AU AU2003900481A patent/AU2003900481A0/en not_active Abandoned
-
2004
- 2004-02-05 US US10/544,796 patent/US7659367B2/en not_active Expired - Fee Related
- 2004-02-05 NZ NZ541738A patent/NZ541738A/xx not_active IP Right Cessation
- 2004-02-05 CA CA2515335A patent/CA2515335C/en not_active Expired - Fee Related
- 2004-02-05 ES ES04708282T patent/ES2372388T3/es not_active Expired - Lifetime
- 2004-02-05 JP JP2006501345A patent/JP4717799B2/ja not_active Expired - Lifetime
- 2004-02-05 KR KR1020057014530A patent/KR101175687B1/ko active IP Right Grant
- 2004-02-05 WO PCT/AU2004/000117 patent/WO2004069871A1/en active Search and Examination
- 2004-02-05 DK DK04708282.1T patent/DK1594895T3/da active
- 2004-02-05 CN CN2004800093227A patent/CN1774448B/zh not_active Expired - Fee Related
- 2004-02-05 AT AT04708282T patent/ATE521636T1/de active
- 2004-02-05 EP EP04708282A patent/EP1594895B1/en not_active Expired - Lifetime
- 2004-02-05 EP EP10191678A patent/EP2357194A1/en not_active Withdrawn
- 2004-02-05 EP EP10191855.5A patent/EP2357195B1/en not_active Expired - Lifetime
- 2004-02-05 KR KR1020127007401A patent/KR101179678B1/ko active IP Right Grant
-
2005
- 2005-08-31 ZA ZA200506991A patent/ZA200506991B/en unknown
-
2006
- 2006-10-25 HK HK06111795.8A patent/HK1091216A1/xx not_active IP Right Cessation
-
2011
- 2011-01-13 JP JP2011005233A patent/JP2011120595A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2515335C (en) | 2013-07-30 |
| NZ541738A (en) | 2006-03-31 |
| EP2357194A1 (en) | 2011-08-17 |
| EP1594895A4 (en) | 2007-05-09 |
| ES2372388T3 (es) | 2012-01-19 |
| CA2515335A1 (en) | 2004-08-19 |
| WO2004069871A1 (en) | 2004-08-19 |
| DK1594895T3 (da) | 2011-12-12 |
| US20060194292A1 (en) | 2006-08-31 |
| EP2357195B1 (en) | 2016-06-29 |
| JP4717799B2 (ja) | 2011-07-06 |
| KR101179678B1 (ko) | 2012-09-04 |
| US7659367B2 (en) | 2010-02-09 |
| KR20120051747A (ko) | 2012-05-22 |
| CN1774448A (zh) | 2006-05-17 |
| ZA200506991B (en) | 2006-06-28 |
| CN1774448B (zh) | 2012-07-18 |
| KR101175687B1 (ko) | 2012-08-22 |
| AU2003900481A0 (en) | 2003-02-20 |
| KR20050103288A (ko) | 2005-10-28 |
| EP1594895B1 (en) | 2011-08-24 |
| EP2357195A1 (en) | 2011-08-17 |
| JP2011120595A (ja) | 2011-06-23 |
| ATE521636T1 (de) | 2011-09-15 |
| JP2007523598A (ja) | 2007-08-23 |
| EP1594895A1 (en) | 2005-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1091216A1 (en) | Growth factor complexes and modulation of cell migration and growth | |
| Bian et al. | Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis | |
| Nikitovic et al. | Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity | |
| Kruger et al. | Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers | |
| Bean et al. | Fiber diameter and seeding density influence chondrogenic differentiation of mesenchymal stem cells seeded on electrospun poly (ε-caprolactone) scaffolds | |
| Whyte et al. | Wnt signaling and injury repair | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| ATE552849T1 (de) | Behandlungsverfahren unter verwendung von ctla-4 antikörpern | |
| IL141141A0 (en) | Targeting pharmaceutical agents to injured tissues | |
| BR112012013035A2 (pt) | fibronectina: quimeras do fator do crescimento | |
| DE60042731D1 (de) | Methode und zubereitung zur hemmung von angiogenese | |
| MY162564A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
| EP2385063A3 (en) | Growth factor complex | |
| Marmotti et al. | Pulsed Electromagnetic Fields Improve Tenogenic Commitment of Umbilical Cord‐Derived Mesenchymal Stem Cells: A Potential Strategy for Tendon Repair—An In Vitro Study | |
| BR112012030821A2 (pt) | vitronectina:fator de crescimento quimeras queratinócitos | |
| NO971341L (no) | Promoter for reseptor tyrosinkinase TIE | |
| MX2022007849A (es) | Anticuerpos especificos contra la claudina 18.2 tumoral. | |
| Jo et al. | Molecular regulators of cellular mechanoadaptation at cell–material interfaces | |
| DE60133104D1 (de) | Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren | |
| WO2003105755A3 (en) | ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION | |
| Yuan et al. | Derivation of human peripheral blood derived endothelial progenitor cells and the role of osteopontin surface modification and eNOS transfection | |
| DE60042793D1 (de) | Inhibitor des hepatozytwachstumsfaktoraktivators und dessen verwendung zur modulation von angiogenese und herzvaskularisierung | |
| Park et al. | Low-intensity ultrasound (LIUS) as an innovative tool for chondrogenesis of mesenchymal stem cells (MSCs) | |
| ATE526945T1 (de) | Verfahren zur erhöhung von fibronectin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200201 |